Valuation Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Delayed Japan Exchange Other stock markets 09:59:49 14/05/2026 am IST			5-day change	1st Jan Change
5,253.00 ^JPY	+1.17%		-1.05%	+8.67%

06:04am	Bain-backed Tanabe Pharma targets three new drug launches a year in Japan	RE
14/05	Takeda to cut about 4,500 jobs in fiscal 2026 as it steps up restructuring	RE

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	62,29,971	54,23,454	67,62,204	65,64,378	67,49,675	82,02,517	-	-
Change	-	-12.95%	24.68%	-2.93%	2.82%	21.52%	-	-
Enterprise Value (EV) ¹	98,62,522	89,19,170	1,06,11,015	1,09,50,330	1,07,25,175	1,21,42,232	1,21,51,969	1,17,19,652
Change	-	-9.57%	18.97%	3.2%	-2.06%	13.21%	0.08%	-3.56%
P/E ratio	16.6x	23.8x	21.3x	45.4x	64.6x	46.4x	35x	25.6x
PBR	1.2x	0.95x	1.06x	0.9x	1x	1.15x	1.16x	1.16x
PEG	-	-0.6x	0.5x	-0.8x	-2.5x	0.6x	1.1x	0.7x
Capitalization / Revenue	1.95x	1.52x	1.68x	1.54x	1.47x	1.99x	1.8x	1.77x
EV / Revenue	3.08x	2.5x	2.63x	2.57x	2.34x	2.68x	2.66x	2.53x
EV / EBITDA	9.23x	8.54x	9.19x	11.6x	9.71x	9.89x	10.4x	9.34x
EV / EBIT	19.4x	19.4x	21.6x	51.1x	31.3x	28x	24.9x	19.8x
EV / FCF	16x	8.92x	28.7x	43.4x	15.5x	14.4x	16.1x	15.3x
FCF Yield	6.26%	11.2%	3.49%	2.31%	6.43%	6.96%	6.2%	6.53%
Dividend per Share ²	180	180	180	188	196	200	203.4	207
Rate of return	4.52%	5.15%	4.14%	4.49%	4.44%	3.85%	3.92%	3.99%
EPS ²	240.7	147.1	204.3	92.09	68.36	122	148.4	202.4
Distribution rate	74.8%	122%	88.1%	204%	287%	178%	137%	102%
Net sales ¹	31,97,812	35,69,006	40,27,478	42,63,762	45,81,600	45,05,700	45,60,200	46,33,684
EBITDA ¹	10,68,940	10,43,995	11,54,905	9,42,077	11,03,982	11,29,888	11,72,164	12,55,426
EBIT ¹	5,09,269	4,60,844	4,90,505	2,14,100	3,42,600	4,08,800	4,87,560	5,91,851
Net income ¹	3,76,005	2,30,059	3,17,017	1,44,067	1,07,900	1,91,800	2,34,173	3,12,845
Net Debt ¹	36,32,551	34,95,716	38,48,811	43,85,952	39,75,500	39,39,715	39,49,453	35,17,136
Reference price ²	3,985.00	3,498.00	4,350.00	4,184.00	4,413.00	5,192.00	5,192.00	5,192.00
Nbr of stocks (in thousands)	15,63,355	15,50,444	15,54,530	15,68,924	15,29,498	15,79,838	-	-
Announcement Date	11/05/21	11/05/22	11/05/23	09/05/24	08/05/25	13/05/26	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	45.99x	2.67x	9.86x	3.87%	5.2TCr
ELI LILLY AND COMPANY	29.04x	10.54x	21.76x	0.69%	91TCr
JOHNSON & JOHNSON	23.97x	5.53x	15.03x	2.38%	55TCr
ABBVIE INC.	25.34x	6.27x	12.75x	3.3%	37TCr
ROCHE HOLDING AG	17x	4.26x	10.49x	3.12%	33TCr
ASTRAZENECA PLC	23.38x	4.85x	13.78x	1.8%	29TCr
NOVARTIS AG	20.45x	5.51x	13.4x	3.04%	28TCr
MERCK & CO., INC.	50.13x	4.67x	17.48x	2.96%	28TCr
NOVO NORDISK A/S	13.42x	4.92x	10.04x	3.76%	21TCr
AMGEN INC.	21.62x	5.9x	10.23x	3%	18TCr
Average	27.03x	5.51x	13.48x	2.79%	34.5TCr
Weighted average by Cap.	26.14x	6.61x	15.45x	2.29%